We recently spoke Lisa Stasi, about the ways Ecolab Life Sciences is helping life sciences companies navigate change management to drive operational excellence, compliance, and timely regulation implementation.

With this video, learn more about the digital solutions helping manufacturers keep pace.

0 0

In a recent video interview, Anil Kane, Executive Director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, introduces OSD Predict, a cutting-edge predictive modeling platform that aims to enhance the efficiency and speed of oral solid dose delivery. This innovative toolbox features multiple tools designed to revolutionize drug formulation and development, including advanced modeling for solubility, compaction simulations, and stability predictions.

OSD Predict streamlines the candidate selection process while minimizing trial and error, significantly shortening the timeline from Phase 1 to Phase 2 and beyond. By integrating AI and machine learning, this platform leverages extensive data for robust predictions, ultimately ensuring that effective medicines reach patients faster.

Don’t miss this great interview to learn more about how OSD Predict can transform drug development and create impactful benefits for the pharmaceutical industry.

2 0

NEW INTERVIEW! We are pleased to share some highlights from our conversation with Michelle Logan from Thermo Fisher Scientific at CPHI 2025!

In our conversation, Michelle talks about the exciting expansion of their U.S. capacity for sterile fill-finish services, particularly focusing on the Ridgefield facility and its impressive capabilities. She also shares insights on the new development lines at the Plainville site, which will enhance collaboration with biotech companies in the Boston area.

3 0

At CPHI, Martin Meeson and Arul Ramadurai revealed how Axplora is scaling new frontiers in API manufacturing — backed by €100M+ invested this year and the confidence of 900+ customers across the globe, including 8 of the world’s top 10 pharma companies.

13 FDA approvals in the past 5 years. 30 years of pioneering cGMP expertise. And a mission that keeps raising the bar in delivery for patients.

2 0

Alway great to talk to Subodh Deshmukh, CEO of Aragen Bioscience, a CRO and CDMO specialising in biologics. Subodh shared insights on Aragen's new production facility, the evolution into a full-scale CDMO, and how they ensure speed, quality, and affordability for clients.

25 0

In this interview, we're joined by Jonathan Guiter, who leads business development for CDMO services at Indena. Jonathan gives us a closer look at Indena, an Italian company that specializes in manufacturing complex and high potent active pharmaceutical ingredients. He shares how Indena supports biotech and pharma companies through every stage of production, from clinical trials to commercial output.

2 0

In this interview, we talked with Shilpa, the Vice President at Enzene Biosciences. Shilpa shares her thoughts on the shift from traditional manufacturing to a more innovative, continuous approach, and how Enzene promotes collaboration and creativity within their R&D team. Join us as we explore the exciting developments at Enzene and Shilpa's vision for the future.

7 0

We are pleased to introduce you to Dr. Ivy Gao, CEO of Sunresin, a pioneering company in resin technology for bioprocessing and life sciences. With their recent nomination for CPHI's Women of the Year Award, Ivy shares insights into her leadership journey, Sunresin’s innovative growth strategies, and her vision for a sustainable future in biopharmaceutical manufacturing.

2 0